NASDAQ: VRCA
Verrica Pharmaceuticals Inc Stock Ownership - Who owns Verrica Pharmaceuticals?

Insider buying vs selling

Have Verrica Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher G. HayesCHIEF LEGAL OFFICER2025-03-174,315$0.65
$2.80kSell

1 of 1

VRCA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRCA insiders and whales buy or sell their stock.

VRCA Shareholders

What type of owners hold Verrica Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul B. Manning374.87%35,409,066$211.39MInsider
Caligan Partners LP97.81%9,239,119$55.16MInstitution
Armistice Capital LLC94.02%8,881,344$53.02MInstitution
Perceptive Advisors LLC75.16%7,099,182$42.38MInsider
Matt Davidson27.06%2,556,179$15.26MInsider
Vanguard Group Inc22.96%2,168,310$12.94MInstitution
John A. Stalfort Iii19.84%1,873,800$11.19MInsider
Millennium Management LLC9.60%907,076$5.42MInstitution
Jayson Rieger9.37%885,278$5.29MInsider
Sovran Advisors LLC7.94%750,391$4.48MInstitution

1 of 3

VRCA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRCA33.62%66.38%Net Selling
PYPD18.47%0.00%
ATHE0.00%0.00%
CLNN1.47%98.53%Net BuyingNet Selling
AKTX0.00%6.84%Net BuyingNet Buying

Verrica Pharmaceuticals Stock Ownership FAQ

Who owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals (NASDAQ: VRCA) is owned by 263.51% institutional shareholders, 520.38% Verrica Pharmaceuticals insiders, and 0.00% retail investors. Paul B. Manning is the largest individual Verrica Pharmaceuticals shareholder, owning 35.41M shares representing 374.87% of the company. Paul B. Manning's Verrica Pharmaceuticals shares are currently valued at $200.42M.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.